CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Data as of , from SEC Form 4 filings.
See up to 3 months of CLOV. The 7-day demo opens the 1M and 3M ranges and puts CLOV on your watchlist.
Start 7-day demoLatest CLOV insider trades
About CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
The SEC lists CLOVER HEALTH INVESTMENTS, CORP. /DE under CIK 0001801170, in hospital and medical service plans. We track it alongside the rest of the Health Care sector.
CLOV Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 13 | 832,884 | $3.74M |
| Grant or award | 4 | 188,004 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CLOV insider transactions (Form 4)
40120 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Tax withholding / forfeiture | Class A Common Stock | 18,076 footnote F1 | $2.81 | $51K | ||
| Tax withholding / forfeiture | Class A Common Stock | 36,923 footnote F2 | $2.54 | $94K | ||
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 6,404 footnote F1 | $2.70 | $17K | ||
| ||||||
| Conrad Wai - Officer | Tax withholding / forfeiture | Class A Common Stock | 98,411 footnote F1 | $2.70 | $266K | |
| ||||||
| Jamie L. Reynoso - Officer | Tax withholding / forfeiture | Class A Common Stock | 12,567 footnote F1 | $2.70 | $34K | |
| Jamie L. Reynoso - Officer | Tax withholding / forfeiture | Class A Common Stock | 8,691 footnote F2 | $2.70 | $23K | |
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 7,459 footnote F1 | $2.47 | $18K | ||
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 85,535 footnote F1 | $2.67 | $228K | ||
| ||||||
| Jamie L. Reynoso - Officer | Open-market sale | Class A Common Stock | 30,385 footnote F1 | $3.58 | $109K | |
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 38,086 footnote F2 | $3.53 | $134K | ||
| Tax withholding / forfeiture | Class A Common Stock | 131,521 footnote F1 | $3.53 | $464K | ||
| ||||||
| Conrad Wai - Officer | Tax withholding / forfeiture | Class A Common Stock | 27,930 footnote F2 | $3.53 | $99K | |
| Conrad Wai - Officer | Tax withholding / forfeiture | Class A Common Stock | 96,448 footnote F1 | $3.53 | $340K | |
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 86,610 footnote F1 | $3.53 | $306K | ||
| Tax withholding / forfeiture | Class A Common Stock | 25,081 footnote F2 | $3.53 | $89K | ||
| ||||||
| Jamie L. Reynoso - Officer | Tax withholding / forfeiture | Class A Common Stock | 101,917 footnote F1 | $3.53 | $360K | |
| Jamie L. Reynoso - Officer | Tax withholding / forfeiture | Class A Common Stock | 29,513 footnote F2 | $3.53 | $104K | |
| ||||||
| Peter J. Kuipers - Officer | Tax withholding / forfeiture | Class A Common Stock | 217,382 footnote F1 | $3.64 | $791K | |
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 48,305 footnote F1 | $2.71 | $131K | ||
| ||||||
| Jamie L. Reynoso - Officer | Open-market sale | Class A Common Stock | 16,514 footnote F1 | $2.69 | $44K | |
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 57,249 footnote F1 | $2.80 | $160K | ||
| ||||||
| Conrad Wai - Officer | Tax withholding / forfeiture | Class A Common Stock | 92,181 footnote F1 | $2.80 | $258K | |
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 82,778 footnote F1 | $2.80 | $232K | ||
| ||||||
| Jamie L. Reynoso - Officer | Tax withholding / forfeiture | Class A Common Stock | 71,432 footnote F1 | $2.80 | $200K | |
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 242,580 footnote F1 | $2.80 | $679K | ||
| ||||||
| Jamie L. Reynoso - Officer | Tax withholding / forfeiture | Class A Common Stock | 8,706 footnote F1 | $2.59 | $23K | |
| Jamie L. Reynoso - Officer | Open-market sale | Class A Common Stock | 2,012 footnote F2 | $2.65 | $5K | |
| ||||||
| Tax withholding / forfeiture | Class A Common Stock | 308,950 footnote F1 | $2.62 | $809K | ||
| ||||||
| Jamie L. Reynoso - Officer | Open-market sale | Class A Common Stock | 4,914 | $3.09 | $15K | |
| Jamie L. Reynoso - Officer | Grant or award | Class A Common Stock | 518,000 | $0.00 | - | |
| Jamie L. Reynoso - Officer | Tax withholding / forfeiture | Class A Common Stock | 52,967 | $1.23 | $65K | |
| Tax withholding / forfeiture | Class A Common Stock | 6,403 | $3.14 | $20K | ||
| Conrad Wai - Officer | Tax withholding / forfeiture | Class A Common Stock | 98,412 | $3.06 | $301K | |
| Jamie L. Reynoso - Officer | Tax withholding / forfeiture | Class A Common Stock | 12,567 | $3.06 | $38K | |
| Jamie L. Reynoso - Officer | Tax withholding / forfeiture | Class A Common Stock | 8,691 | $3.14 | $27K | |
| Anna U. Loengard - Director | Open-market purchase | Class A Common Stock | 12,000 | $2.60 | $31K | |
| Anna U. Loengard - Director | Open-market purchase | Class A Common Stock | 14,500 | $2.59 | $38K | |
| Tax withholding / forfeiture | Class A Common Stock | 7,459 | $2.57 | $19K | ||
| Vivek Garipalli - Director | Open-market purchase | Class A Common Stock | 415,000 | $2.24 | $930K | |
| Vivek Garipalli - Director | Open-market purchase | Class A Common Stock | 31,980 | $2.17 | $69K | |
See every CLOV filing on record
These pages show the latest 90 of 120 Form 4 filings on record. The 7-day demo shows all 120, and sign-up brings you back to this table.
Recent CLOV Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JAMIE REYNOSO | Officer | 2,006 | $9K | View on EDGAR | |
| Jamie Reynoso | Officer | 8,706 |
CLOV insider trading FAQ
What is the latest insider trade for CLOV?
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) had 17 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for CLOV runs to 120 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CLOV stock?
No insider purchases of CLOV were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling CLOV stock?
13 insider sales of CLOV were filed in the last 90 days, totaling $3.74M.
Where can I see CLOV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CLOV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jamie L. Reynoso view on EDGAR
- - Jamie L. Reynoso view on EDGAR
- - Brian James Miller view on EDGAR
- - Robert G. Torricelli view on EDGAR
- - Andrew Toy view on EDGAR
- - Jamie L. Reynoso view on EDGAR
- - Joseph Frank Oldakowski view on EDGAR
- - Conrad Wai view on EDGAR
- - Karen Soares view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CLOV's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CLOV with a 7-day demo
- CLOV on your watchlist
- Every CLOV Form 4 filing on record
- Up to 3 months of CLOV price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive